To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
Status:
Recruiting
Trial end date:
2022-10-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment
of Chinese patients with visual impairment due to Diabetic Macular Edema.